GOLGA6B: A Protein Implicated in Cell Adhesion, Migration and Survival

Target Name: GOLGA6B

NCBI ID: G55889

GOLGA6B

GOLGA6B: A Protein Implicated in Cell Adhesion, Migration and Survival

GOLGA6B (GOLGA6D) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the GOLGA family of proteins, which are involved in the regulation of cell signaling pathways. GOLGA6B has been shown to play a role in several cellular processes, including cell adhesion, migration, and survival.

One of the unique features of GOLGA6B is its ability to interact with several different proteins, including the protein Tau. Tau is a protein that is involved in the regulation of cell signaling pathways, and is often associated with the development of neurodegenerative diseases. GOLGA6B has been shown to interact with Tau and to regulate the activity of Tau proteins.

Another protein that has been shown to interact with GOLGA6B is the protein p53. P53 is a protein that is involved in the regulation of cell signaling pathways, and is often associated with the regulation of DNA damage repair. GOLGA6B has been shown to interact with p53 and to regulate the activity of p53.

In addition to its interactions with Tau and p53, GOLGA6B has also been shown to interact with several other proteins, including the protein Ago. Ago is a protein that is involved in the regulation of cell signaling pathways, and is often associated with the regulation of DNA-protein interactions. GOLGA6B has been shown to interact with Ago and to regulate the activity of Ago.

GOLGA6B has been shown to play a role in several cellular processes, including cell adhesion, migration, and survival. For example, GOLGA6B has been shown to play a role in the regulation of cell adhesion, by interacting with the protein cadherin. This interaction between GOLGA6B and cadherin has been shown to regulate the movement of cells along the surface of a membrane, and to influence the formation of tissues such as the skin and the heart.

In addition to its role in cell adhesion, GOLGA6B has also been shown to play a role in the regulation of cell migration. For example, GOLGA6B has been shown to interact with the protein vimentin, which is involved in the regulation of cell shape and movement. This interaction between GOLGA6B and vimentin has been shown to regulate the movement of cells along the surface of a membrane, and to influence the formation of tissues such as the brain and the heart.

GOLGA6B has also been shown to play a role in the regulation of cell survival. For example, GOLGA6B has been shown to interact with the protein Bcl-2, which is involved in the regulation of cell survival. This interaction between GOLGA6B and Bcl-2 has been shown to regulate the activity of Bcl-2, and to influence the ability of cells to survive in the face of environmental stress.

GOLGA6B has been shown to play a role in several diseases, including cancer. For example, GOLGA6B has been shown to be involved in the regulation of cell signaling pathways in cancer cells, and to play a role in the development of cancer. This interaction between GOLGA6B and cancer cells may be a potential drug target or biomarker for cancer therapies.

In conclusion, GOLGA6B is a protein that is involved in several cellular processes, including cell adhesion, migration, and survival. It has been shown to interact with several different proteins, including Tau, p53, and Ago. GOLGA6B has been shown to play a role in the regulation of cell signaling pathways, and is potential drug

Protein Name: Golgin A6 Family Member B

The "GOLGA6B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA6B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets